On Tuesday, Shares of Sirius XM Holdings Inc. (NASDAQ:SIRI), lost -0.25% to $3.95.
Sirius XM Canada Holdings Inc. parent of Sirius XM Canada Inc., advised that, effective September 4, 2015 , Mr. Michael Washinushi , Chief Financial Officer, will be leaving the Company to pursue other business opportunities.
The Company, in coordination with the Board of Directors, has commenced a search for Mr. Washinushi’s replacement. Mr. Washinushi will stay on full-time with SiriusXM Canada until September 4 , after which he will act as an advisor to the Company through to the end of 2015, to assist ensure a smooth transition.
Sirius XM Holdings Inc., through its auxiliaries, provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, counting various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and local traffic reports for 22 metropolitan markets.
Shares of Parker-Hannifin Corporation (NYSE:PH), declined -4.01% to $107.90, during its last trading session.
Parker-Hannifin Corporation stated results for the fiscal 2015 fourth quarter and full year ended June 30, 2015. Fiscal 2015 fourth quarter sales were $3.14 billion, contrast with $3.53 billion in the same period a year ago, reflecting the effect of currency rate changes and weak end market demand. Fiscal 2015 fourth quarter net income was $179.6 million, contrast with $301.2 million in the preceding year quarter. Fiscal 2015 fourth quarter earnings per share were $1.27, contrast with $1.98 per share in the preceding year quarter. Adjusted earnings per share were $1.43 in the fiscal 2015 fourth quarter, contrast with $2.06 per share in the preceding year quarter. Fiscal 2015 fourth quarter earnings were negatively influenced by $0.30 per share as a result of a higher effective tax rate due to changes in the geographic mix of pre-tax profits and discrete items booked in the quarter.
Fiscal 2015 full year sales were $12.7 billion, contrast with $13.2 billion in fiscal 2014, primarily influenced by the effect of currency rate changes and weakening end market demand in the second half of the fiscal year. Net income for fiscal 2015 was $1.01 billion, contrast with $1.04 billion in fiscal 2014. Fiscal 2015 earnings per share were $6.97, contrast with $6.87 per share in fiscal 2014. Adjusted earnings per share for fiscal 2015 were $7.25, contrast with $6.94 in the preceding year. Fiscal 2015 full year results comprised of $0.38 per share in transaction currency gains that are not anticipated to repeat in fiscal 2016. Despite difficult market conditions, cash flow from operations for fiscal 2015 was $1.3 billion or 10.2 percent of sales contrast with $1.4 billion or 10.5 percent of sales in the preceding year.
Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for various mobile, industrial, and aerospace markets worldwide. It operates through two segments, Diversified Industrial and Aerospace Systems.
Finally, Endologix Inc. (NASDAQ:ELGX), ended its last trade with -14.58% loss, and closed at $12.01.
Endologix declared financial results for the three and six months ended June 30, 2015.
Financial Results
Global revenue in the second quarter of 2015 was $39.5 million, a 3% enhance from $38.3 million in the second quarter of 2014. For the six months ended June 30, 2015, global revenue raised 6% to $76.1 million, contrast to $71.6 million for the six months ended June 30, 2014. On a constant currency basis, revenue for the second quarter and six months ended June 30, 2015 raised 8% and 11%, respectively.
U.S. revenue in the second quarter of 2015 was $28.8 million, a 14% sequential enhance from the first quarter of 2015 and a 3% enhance contrast with $28.0 million in the second quarter of 2014. International revenue was $10.7 million, a 4% enhance contrast to $10.3 million in the second quarter of 2014. On a constant currency basis, second quarter international revenue raised 20%. European revenue was $7.9 million, a 1% enhance as contrast to $7.8 million in the second quarter of 2014, but 23% growth on a constant currency basis.
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular repair (EVAR) products, counting EVAR stent graft and catheter delivery system under the brand names Powerlink, IntuiTrak, AFX, and VELA Proximal Endograft.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
